0 items USD 0.00Search
Your search for "ark patent intelligence metformin dapagliflozin patent extension data exclusivity expiry 1" gave back 1465806 results.
Pharmaceutical Lifecycle Management Strategies in 2017 Summary GBI Research’s latest report, "Pharmaceutical Lifecycle Management Strategies in...
CBR Pharma Insights
April 2017
Price: USD 2,995.00
The Future of Generic Drugs and Strategies for Commercial Success Summary GBI Research’s latest report “The Future of Generic Drugs and Strategies...
Catalog:
CBR Pharma Insights
September 2016
Price: USD 2,995.00
A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product, that is manufactured without a license...
Catalog:
Signals and Systems Telecom
February 2015
Price: USD 2,500.00
Globally Pharmaceutical markets are showing rapid growth and in coming years expected to evolve further in the field of research and development,...
Catalog:
IQ4I
May 2021
Price: USD 4,950.00
Competitor Analysis: Anti-VEGF and Anti-VEGF-R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis – a 2017 Update The Competitive...
Catalog:
La Merie Publishing
November 2017
Price: USD 525.00
With much-awaited approval of biosimilar interchangeability by FDA, the dynamics in the much nascent US biosimilars market is about to change with...
Catalog:
Rockville Research
January 2017
Price: USD 1,200.00
The global Pet Daily Necessities market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a...
Catalog:
GIR
February 2024
Price: USD 3,480.00
The Mid-Size Pharmaceutical Market: Market Assessment, Growth Forecasts and Strategic Consolidations for Key Players Summary GBI Research’s latest...
Catalog:
CBR Pharma Insights
May 2018
Price: USD 2,995.00
Life Cycle Management Strategies Optimizing revenues and defending generic competition discusses various stages of product lifecycle management (LCM...
Catalog:
CBR Pharma Insights
July 2015
Price: USD 2,995.00
CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors The present Competitive Intelligence Report about CD20 Antibodies - Rituximab...
Catalog:
La Merie Publishing
February 2014
Price: USD 401.00
The global Empagliflozin, Dapagliflozin and Canagliflozin market size was valued at USD million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
July 2023
Price: USD 3,480.00
Polymerase Chain Reaction (PCR) is a novel technique which amplifies the amount of target nucleic acid in every cycle. PCR has three steps such as...
Catalog:
IQ4I
November 2019
Price: USD 4,950.00
Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics...
Catalog:
CBR Pharma Insights
January 2019
Price: USD 2,995.00
As an extension of the intelligent medicine cabinet, the intelligent medicine rack is used to store the large infusion and heterogeneous drugs that...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Dapagliflozin is a medication used to treat type 2 diabetes and, with certain restrictions, type 1 diabetes. The global Dapagliflozin API market was...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Filter By Report Date
Filter By Industry
Filter By Country
- (-) Remove Global filter Global
- Middle East (3) Apply Middle East filter
- Africa (2) Apply Africa filter
- Latin America (2) Apply Latin America filter
- America (1) Apply America filter
- Americas (1) Apply Americas filter
- Asia (1) Apply Asia filter
- BRIC (1) Apply BRIC filter
- Caribbean (1) Apply Caribbean filter
- Oceania (1) Apply Oceania filter
